ABBOTT LABORATORIES Short-term Debt
ABBOTT LABORATORIES (ABT) had Short-term Debt of $0 as of 2021-12-31, per its 10-K filed 2024-02-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ShortTermBorrowings · last filed 2024-02-16
- 2021-12-31: Short-term Debt $0.00.
- 2021-09-30: Short-term Debt $197.00M.
- 2021-06-30: Short-term Debt $199.00M.
- 2021-03-31: Short-term Debt $199.00M.
| Period end | Short-term Debt | Short-term Debt as first filed |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2024-02-16 | |
| 2021-09-30 | $197.00M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $199.00M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $199.00M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $213.00M 10-K · filed 2022-02-18 | |
| 2020-09-30 | $208.00M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $205.00M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $204.00M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $201.00M 10-K · filed 2021-02-19 | |
| 2019-09-30 | $204.00M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $204.00M 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $201.00M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $200.00M 10-K · filed 2020-02-21 | |
| 2018-09-30 | $211.00M 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $341.00M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $230.00M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $206.00M 10-K · filed 2019-02-22 | |
| 2017-09-30 | $211.00M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $218.00M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $207.00M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $1.32B 10-K · filed 2018-02-16 | |
| 2016-09-30 | $2.53B 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $2.89B 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $2.61B 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $3.13B 10-K · filed 2017-02-17 | |
| 2015-09-30 | $2.37B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $2.87B 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $2.92B 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $4.38B 10-K · filed 2016-02-19 | |
| 2014-09-30 | $4.38B 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $3.95B 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $4.37B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $3.16B 10-K · filed 2015-02-27 | |
| 2013-09-30 | $4.60B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $4.26B 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $3.36B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $2.08B 10-K · filed 2014-02-21 | $2.08B 10-K · filed 2013-02-15 |
| 2012-09-30 | $3.21B 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $5.06B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $3.76B 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $2.35B 10-K · filed 2013-02-15 | |
| 2011-09-30 | $3.59B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $5.57B 10-Q · filed 2011-08-04 | |
| 2011-03-31 | $4.72B 10-Q · filed 2011-05-06 | |
| 2010-12-31 | $4.35B 10-K · filed 2013-02-15 | |
| 2010-09-30 | $3.59B 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $3.65B 10-Q · filed 2010-08-05 | |
| 2010-03-31 | $5.73B 10-Q · filed 2010-05-04 | |
| 2009-12-31 | $4.98B 10-K · filed 2012-02-21 | |
| 2009-09-30 | $4.04B 10-Q · filed 2009-11-06 | |
| 2009-06-30 | $4.30B 10-Q · filed 2009-08-07 | |
| 2008-12-31 | $1.69B 10-K · filed 2011-02-18 | |
| 2007-12-31 | $1.83B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |